Media stories about Danaher Corporation (NYSE:DHR) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group rates the sentiment of media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Danaher Corporation earned a news sentiment score of 0.21 on Accern’s scale. Accern also assigned news stories about the conglomerate an impact score of 46.3928751713074 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Here are some of the media headlines that may have effected Accern Sentiment’s analysis:

Danaher Corporation (NYSE:DHR) last released its earnings results on Thursday, October 19th. The conglomerate reported $1.00 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.95 by $0.05. The firm had revenue of $4.53 billion during the quarter, compared to analysts’ expectations of $4.47 billion. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.87 EPS.

The firm also recently declared a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were issued a $0.14 dividend. This represents a $0.56 annualized dividend and a yield of 0.60%. The ex-dividend date was Thursday, September 28th. Danaher Corporation’s dividend payout ratio (DPR) is presently 16.52%.

A number of equities research analysts recently weighed in on DHR shares. J P Morgan Chase & Co reaffirmed an “overweight” rating and set a $95.00 price target on shares of Danaher Corporation in a report on Friday, September 8th. BidaskClub lowered shares of Danaher Corporation from a “hold” rating to a “sell” rating in a report on Saturday, July 8th. Wells Fargo & Company reaffirmed a “market perform” rating on shares of Danaher Corporation in a report on Saturday, July 22nd. Zacks Investment Research raised shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price target for the company in a report on Thursday, October 5th. Finally, Citigroup Inc. set a $96.00 price target on shares of Danaher Corporation and gave the company a “buy” rating in a report on Friday, July 21st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $93.31.

COPYRIGHT VIOLATION WARNING: “Danaher Corporation (DHR) Receiving Somewhat Positive Press Coverage, Report Shows” was reported by Watch List News and is the property of of Watch List News. If you are reading this story on another publication, it was stolen and republished in violation of international copyright legislation. The correct version of this story can be viewed at

In other Danaher Corporation news, CFO Daniel L. Comas sold 88,184 shares of the business’s stock in a transaction on Monday, October 23rd. The shares were sold at an average price of $91.02, for a total value of $8,026,507.68. Following the sale, the chief financial officer now owns 227,816 shares of the company’s stock, valued at approximately $20,735,812.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider William King sold 43,688 shares of the business’s stock in a transaction on Thursday, August 31st. The shares were sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the completion of the sale, the insider now directly owns 45,748 shares in the company, valued at approximately $3,790,679.28. The disclosure for this sale can be found here. Insiders sold a total of 279,628 shares of company stock worth $25,304,394 in the last three months. Insiders own 12.20% of the company’s stock.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Insider Buying and Selling by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.